M0821

Moexipril 盐酸盐

powder, ≥98% (HPLC)

• 同義詞: (3S)-2-[(2S)-2-[[(1S)-1-(Ethoxycarbonyl)-3-phenylpropyl]amino]-1-oxopropyl]-1,2,3,4-tetrahydro-6,7-dimethoxy-3-isoquinolinecarboxylic acid 盐酸盐
• 經驗公式（希爾表示法）: C₂₇H₃₅N₂O₇Cl
• CAS號碼: 82586-52-5
• 分子量：: 535.03
• MDL號碼: MFCD00940481
• 分類程式碼代碼: 12352200
• PubChem物質ID: 329817832
• NACRES: NA.77

屬性

• 品質等級: 100
• 化驗: ≥98% (HPLC)
• 形狀: powder
• 溶解度: H₂O: 32 mg/mL
• 起源: UCB Inc.
• 儲存溫度: 2-8°C
• SMILES 字串: Cl.CCOC(=O)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N2Cc3cc(OC)c(OC)cc3C[C@H]2C(O)=O
• InChI: 1S/C27H34N2O7.ClH/c1-5-36-27(33)21(12-11-18-9-7-6-8-10-18)28-17(2)25(30)29-16-20-15-24(35-4)23(34-3)14-19(20)13-22(29)26(31)32;/h6-10,14-15,17,21-22,28H,5,11-13,16H2,1-4H3,(H,31,32);1H/t17-,21-,22-;/m0./s1
• InChI 密鑰: JXRAXHBVZQZSIC-JKVLGAQCSA-N
• 基因資訊: human ... ACE(1636)

描述

生化／生理作用

Moexipril is an ACE-Inhibitor; Antihypertensive; Unlike other ACE inhibitors, prolongs QT interval leading to torsades de pointes and cardiad arrhythmia;

特點和優勢

This compound is featured on the Angiotensin Receptors page of the Handbook of Receptor Classification and Signal Transduction. To browse other handbook pages, click here.

This compound was developed by UCB Inc.. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.

安全資訊

• 象形圖: GHS09
• 訊號詞: Warning
• 危險聲明: H400
• 防範說明: P273 - P391 - P501
• 危險分類: Aquatic Acute 1
• 儲存類別代碼: 11 - Combustible Solids
• 水污染物質分類（WGK）: WGK 3
• 閃點（°F）: Not applicable
• 閃點（°C）: Not applicable
• 個人防護裝備: Eyeshields, Gloves